Pralym^®

Proprietary Name: Pralym®
Generic Name: Pralatrexate
Dosage Form: Vial
Strengths: 20 mg/1 ml
Indications: Peripheral T-cell Lymphoma (PTCL)

Pralatrexate

Product Information

Oncology

Pralatrexate is indicated for the treatment of peripheral T-cell lymphoma (PTCL).